サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/04/08 | 4,200 | 4,255 | 4,140 | 4,230 | -210 | -4.7% | 357,200 |
| 2022/04/07 | 4,450 | 4,465 | 4,410 | 4,440 | -60 | -1.3% | 120,800 |
| 2022/04/06 | 4,560 | 4,570 | 4,490 | 4,500 | -40 | -0.9% | 51,900 |
| 2022/04/05 | 4,550 | 4,550 | 4,515 | 4,540 | +40 | +0.9% | 61,300 |
| 2022/04/04 | 4,545 | 4,545 | 4,480 | 4,500 | +10 | +0.2% | 47,200 |
| 2022/04/01 | 4,440 | 4,505 | 4,405 | 4,490 | +30 | +0.7% | 72,700 |
| 2022/03/31 | 4,500 | 4,520 | 4,455 | 4,460 | +5 | +0.1% | 105,500 |
| 2022/03/30 | 4,560 | 4,560 | 4,440 | 4,455 | -120 | -2.6% | 107,900 |
| 2022/03/29 | 4,615 | 4,615 | 4,555 | 4,575 | -45 | -1% | 88,200 |
| 2022/03/28 | 4,650 | 4,650 | 4,615 | 4,620 | +5 | +0.1% | 37,200 |
| 2022/03/25 | 4,575 | 4,615 | 4,565 | 4,615 | +45 | +1% | 64,700 |
| 2022/03/24 | 4,605 | 4,630 | 4,505 | 4,570 | -25 | -0.5% | 84,400 |
| 2022/03/23 | 4,620 | 4,630 | 4,540 | 4,595 | +25 | +0.5% | 63,200 |
| 2022/03/22 | 4,540 | 4,595 | 4,500 | 4,570 | +95 | +2.1% | 109,400 |
| 2022/03/18 | 4,500 | 4,530 | 4,450 | 4,475 | -80 | -1.8% | 221,700 |
| 2022/03/17 | 4,570 | 4,585 | 4,525 | 4,555 | -15 | -0.3% | 81,700 |
| 2022/03/16 | 4,640 | 4,650 | 4,570 | 4,570 | -25 | -0.5% | 71,500 |
| 2022/03/15 | 4,520 | 4,615 | 4,505 | 4,595 | +85 | +1.9% | 81,700 |
| 2022/03/14 | 4,460 | 4,535 | 4,425 | 4,510 | +45 | +1% | 87,700 |
| 2022/03/11 | 4,380 | 4,490 | 4,380 | 4,465 | -55 | -1.2% | 119,200 |
| 2022/03/10 | 4,425 | 4,530 | 4,395 | 4,520 | +160 | +3.7% | 107,900 |
| 2022/03/09 | 4,280 | 4,385 | 4,270 | 4,360 | +75 | +1.8% | 108,500 |
| 2022/03/08 | 4,270 | 4,350 | 4,270 | 4,285 | -5 | -0.1% | 121,000 |
| 2022/03/07 | 4,350 | 4,355 | 4,275 | 4,290 | -90 | -2.1% | 78,200 |
| 2022/03/04 | 4,460 | 4,470 | 4,370 | 4,380 | -75 | -1.7% | 83,300 |
| 2022/03/03 | 4,435 | 4,490 | 4,425 | 4,455 | +60 | +1.4% | 39,100 |
| 2022/03/02 | 4,440 | 4,490 | 4,390 | 4,395 | -85 | -1.9% | 84,200 |
| 2022/03/01 | 4,460 | 4,515 | 4,430 | 4,480 | -85 | -1.9% | 108,600 |
| 2022/02/28 | 4,455 | 4,570 | 4,435 | 4,565 | +145 | +3.3% | 96,300 |
| 2022/02/25 | 4,450 | 4,450 | 4,385 | 4,420 | -30 | -0.7% | 59,800 |
| 2022/02/24 | 4,460 | 4,470 | 4,385 | 4,450 | +60 | +1.4% | 92,800 |
| 2022/02/22 | 4,410 | 4,420 | 4,380 | 4,390 | -35 | -0.8% | 64,100 |
| 2022/02/21 | 4,460 | 4,480 | 4,415 | 4,425 | -105 | -2.3% | 43,900 |
| 2022/02/18 | 4,405 | 4,535 | 4,395 | 4,530 | +80 | +1.8% | 98,700 |
| 2022/02/17 | 4,475 | 4,535 | 4,425 | 4,450 | -50 | -1.1% | 143,500 |
| 2022/02/16 | 4,455 | 4,540 | 4,430 | 4,500 | -45 | -1% | 141,600 |
| 2022/02/15 | 4,465 | 4,610 | 4,450 | 4,545 | -60 | -1.3% | 160,400 |
| 2022/02/14 | 4,575 | 4,625 | 4,560 | 4,605 | +5 | +0.1% | 80,700 |
| 2022/02/10 | 4,580 | 4,630 | 4,570 | 4,600 | +30 | +0.7% | 100,400 |
| 2022/02/09 | 4,545 | 4,575 | 4,500 | 4,570 | +60 | +1.3% | 82,700 |
| 2022/02/08 | 4,510 | 4,540 | 4,505 | 4,510 | +5 | +0.1% | 46,800 |
| 2022/02/07 | 4,470 | 4,510 | 4,450 | 4,505 | +15 | +0.3% | 49,300 |
| 2022/02/04 | 4,465 | 4,510 | 4,440 | 4,490 | +45 | +1% | 80,500 |
| 2022/02/03 | 4,385 | 4,475 | 4,375 | 4,445 | +55 | +1.3% | 68,700 |
| 2022/02/02 | 4,295 | 4,395 | 4,290 | 4,390 | +90 | +2.1% | 114,300 |
| 2022/02/01 | 4,230 | 4,320 | 4,230 | 4,300 | -35 | -0.8% | 123,000 |
| 2022/01/31 | 4,340 | 4,360 | 4,305 | 4,335 | +5 | +0.1% | 110,400 |
| 2022/01/28 | 4,360 | 4,385 | 4,320 | 4,330 | +5 | +0.1% | 66,800 |
| 2022/01/27 | 4,375 | 4,405 | 4,305 | 4,325 | -40 | -0.9% | 74,700 |
| 2022/01/26 | 4,410 | 4,420 | 4,360 | 4,365 | -45 | -1% | 51,800 |
751～
800
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
